Identification of Avramr1 from Phytophthorainfestans using prolonged study and cDNA pathogen-enrichment sequencing (PenSeq)
Potato late blight, introduced on by the oomycete pathogen Phytophthorainfestans, significantly hampers potato manufacturing. Recently, a model new Resistance to Phytophthorainfestans (Rpi) gene, Rpi-amr1, was cloned from a wild Solanum species, Solanumamericanum.
Identification of the corresponding acknowledged effector (Avirulence or Avr) genes from P. infestans is crucial to elucidating their naturally occurring sequence variation, which in flip informs the potential sturdiness of the cognate late blight resistance. To ascertain the P. infestans effector acknowledged by Rpi-amr1, we screened obtainable RXLR effector libraries and used prolonged study and cDNA pathogen-enrichment sequencing (PenSeq) on Four P. infestans isolates to find the untested effectors.
Using single-molecule real-time sequencing (SMRT) and cDNA PenSeq, we acknowledged 47 extraordinarily expressed effectors from P. infestans, along with PITG_07569, which triggers a extraordinarily explicit cell lack of life response when transiently coexpressed with Rpi-amr1 in Nicotianabenthamiana, suggesting that PITG_07569 is Avramr1. Proper right here we show that prolonged study and cDNA PenSeq permits the identification of full-length RXLR effector households and their expression profile. This look at has revealed key insights into the evolution and polymorphism of a flowery RXLR effector family that is associated to the recognition by Rpi-amr1.
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
QP10912-2ug |
EnQuireBio |
2ug |
EUR 186 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
QP10912-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046 |
ReliaTech |
20 µg |
EUR 194.25 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046S |
ReliaTech |
5 µg |
EUR 94.5 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
PROTQ2F842 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
ov-VEGF-E (Orf virus) (Recombinant) Human |
GWB-C8AD60 |
GenWay Biotech |
0.005 mg |
Ask for price |
VEGFE protein (Orf virus) |
30R-AV011 |
Fitzgerald |
5 ug |
EUR 381 |
|
Description: Purified recombinant VEGFE protein (Orf virus) |
Recombinant Orf Virus VEGFE Protein |
VAng-Lsx0417-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
Recombinant Orf Virus VEGFE Protein [His] |
VAng-Lsx0418-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Deoxybrevianamide E |
D083-1MG |
TOKU-E |
1 mg |
EUR 187.71 |
|
Description: C21H25N3O2 |
Deoxybrevianamide E |
D083-5MG |
TOKU-E |
5 mg |
EUR 656.34 |
|
Description: C21H25N3O2 |
Berkeleylactone E |
B087-1MG |
TOKU-E |
1 mg |
EUR 142.63 |
|
Description: C20H32O7 |
Berkeleylactone E |
B087-5MG |
TOKU-E |
5 mg |
EUR 498.97 |
|
Description: C20H32O7 |
Chevalone E |
C257-0.5MG |
TOKU-E |
0.5 mg |
EUR 150.43 |
|
Description: C20H24O4 |
Chevalone E |
C257-2.5MG |
TOKU-E |
2.5 mg |
EUR 525.85 |
|
Description: C20H24O4 |
Cytochalasin E |
C197-1MG |
TOKU-E |
1 mg |
EUR 77.6 |
|
Description: C28H33NO7 |
Cytochalasin E |
C197-5MG |
TOKU-E |
5 mg |
EUR 270.51 |
|
Description: C28H33NO7 |
Roquefortine E |
R035-1MG |
TOKU-E |
1 mg |
EUR 146.96 |
|
Description: C27H31N5O2 |
Roquefortine E |
R035-5MG |
TOKU-E |
5 mg |
EUR 513.71 |
|
Description: C27H31N5O2 |
Oligomycin E |
O021-1MG |
TOKU-E |
1 mg |
EUR 207.65 |
|
Description: C45H72O13 |
Oligomycin E |
O021-5MG |
TOKU-E |
5 mg |
EUR 726.13 |
|
Description: C45H72O13 |
Paraherquamide E |
P070-0.5MG |
TOKU-E |
0.5 mg |
EUR 265.74 |
|
Description: C28H35N3O4 |
Paraherquamide E |
P070-2.5MG |
TOKU-E |
2.5 mg |
EUR 928.58 |
|
Description: C28H35N3O4 |
Phenelfamycin E |
P078-1MG |
TOKU-E |
1 mg |
EUR 207.65 |
|
Description: C65H95NO21 |
Phenelfamycin E |
P078-5MG |
TOKU-E |
5 mg |
EUR 726.13 |
|
Description: C65H95NO21 |
Azithromycin impurity E EvoPure® |
A074-5MG |
TOKU-E |
5 mg |
EUR 593.04 |
|
Description: C36H68N2O12 |
Hepatitis E virus |
Oneq-H498-OneqH498100R |
Bioingentech |
Oneq-H498-100R |
EUR 1028 |
Hepatitis E virus |
Oneq-H498-OneqH498150R |
Bioingentech |
Oneq-H498-150R |
EUR 1438 |
Hepatitis E virus |
Oneq-H498-OneqH49850R |
Bioingentech |
Oneq-H498-50R |
EUR 728 |
Hepatitis E virus |
PCR-H498-PCRH49848R |
Bioingentech |
PCR-H498-48R |
EUR 485 |
Hepatitis E virus |
PCR-H498-PCRH49896R |
Bioingentech |
PCR-H498-96R |
EUR 685 |
Hepatitis E virus ORF 3 Recombinant Protein |
53-335 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-336 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-337 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 recombinant antigen |
8942 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB. |
Hepatitis E virus ORF 2 recombinant antigen |
8943 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB. |
Hepatitis E virus ORF 3 recombinant antigen |
8944 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Hepatitis E virus ORF 3 recombinant antigen for ELISA,WB. |
Hepatitis E Virus ORF3 Protein |
20-abx260138 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF3 (Recombinant) |
22060181-1 |
Glycomatrix |
100 µg |
EUR 264.47 |
Recombinant Hepatitis E Virus ORF3 |
7-07450 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
7-07451 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
7-07452 |
CHI Scientific |
1000µg |
Ask for price |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
20-abx263083 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E virus (ratHEV) |
Oneq-V372-OneqV372100R |
Bioingentech |
Oneq-V372-100R |
EUR 1028 |
Hepatitis E virus (ratHEV) |
Oneq-V372-OneqV372150R |
Bioingentech |
Oneq-V372-150R |
EUR 1438 |
Hepatitis E virus (ratHEV) |
Oneq-V372-OneqV37250R |
Bioingentech |
Oneq-V372-50R |
EUR 728 |
Hepatitis E virus (ratHEV) |
PCR-V372-PCRV37248R |
Bioingentech |
PCR-V372-48R |
EUR 485 |
Hepatitis E virus (ratHEV) |
PCR-V372-PCRV37296R |
Bioingentech |
PCR-V372-96R |
EUR 685 |
Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant) |
22060748-1 |
Glycomatrix |
2 µg |
EUR 146.42 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
7-01759 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
7-01760 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
7-01761 |
CHI Scientific |
1mg |
Ask for price |
Hepatitis E Virus protein |
30-AH29 |
Fitzgerald |
1 mg |
EUR 895 |
|
Description: Hepatitis E Virus recombinant protein |
Hepatitis E Virus protein |
30R-AH054X |
Fitzgerald |
500 ug |
EUR 840 |
|
Description: Hepatitis E Virus Mosaic recombinant protein |
Hepatitis E Virus antibody |
70R-HR003 |
Fitzgerald |
100 ug |
EUR 295 |
|
Description: Affinity purified Rabbit polyclonal Hepatitis E Virus antibody |
West Nile Virus E Prot. |
GWB-41C2BC |
GenWay Biotech |
0.1 mg |
Ask for price |
|
Hepatitis E virus PCR kit |
PCR-H498-48R |
Bioingentech |
50T |
EUR 987.6 |
Hepatitis E virus PCR kit |
PCR-H498-96R |
Bioingentech |
100T |
EUR 1335.6 |
Hepatitis E Virus ORF2 (452-617) Protein |
20-abx260268 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
20-abx260269 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
20-abx260270 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus protein (HRP) |
65-IH35 |
Fitzgerald |
1 ml |
EUR 1100 |
|
Description: Purified recombinant Hepatitis E Virus protein (HRP) |
Hepatitis E Virus ORF2 (452-617), (Recombinant) |
22060180-1 |
Glycomatrix |
100 µg |
EUR 264.47 |
Hepatitis E Virus ORF2 (403-461), (Recombinant) |
22060182-1 |
Glycomatrix |
100 µg |
EUR 264.47 |
Hepatitis E Virus ORF2 (633-659), (Recombinant) |
22060183-1 |
Glycomatrix |
100 µg |
EUR 264.47 |
Recombinant Hepatitis E Virus ORF2 (633-659) |
7-07441 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (633-659) |
7-07442 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (633-659) |
7-07443 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (403-461) |
7-07444 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (403-461) |
7-07445 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (403-461) |
7-07446 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (452-617) |
7-07447 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (452-617) |
7-07448 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Hepatitis E Virus ORF2 (452-617) |
7-07449 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant Zika Virus E Protein |
VAng-Lsx0581-100g |
Creative Biolabs |
100 µg |
EUR 1365.6 |
Description: Zika Virus Envelope, recombinant protein from Insect cells. |
Anti-Hepatitis E Virus Antibody |
18606 |
Genovis AB |
100ug |
EUR 397 |
Hantaan Virus Nucleoprotein (E. coli) |
REC31725-100 |
The Native Antigen Company |
0.1 |
EUR 348.29 |
Description: Hantavirus Nucleocapsid (N) protein produced in E. coli. |
Hantaan Virus Nucleoprotein (E. coli) |
REC31725-500 |
The Native Antigen Company |
0.5 |
EUR 1217.07 |
Description: Hantavirus Nucleocapsid (N) protein produced in E. coli. |
Recombinant (E.Coli) Hepatitis E Virus (HEV) ORF3 |
RP-531 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
Hepatitis E virus RT PCR kit |
RTq-H498-100R |
Bioingentech |
100T |
EUR 1573.2 |
Hepatitis E virus RT PCR kit |
RTq-H498-150R |
Bioingentech |
150T |
EUR 2144.4 |
Hepatitis E virus RT PCR kit |
RTq-H498-50R |
Bioingentech |
50T |
EUR 1155.6 |
Hepatitis E virus (ratHEV) PCR kit |
PCR-V372-48R |
Bioingentech |
50T |
EUR 987.6 |
Hepatitis E virus (ratHEV) PCR kit |
PCR-V372-96R |
Bioingentech |
100T |
EUR 1335.6 |
VEGF (165): Human Recombinant E Coli |
GWB-BDEFEF |
GenWay Biotech |
1 mg |
Ask for price |
Hepatitis E virus genotype 1 Protein ORF3 (ORF3) |
1-CSB-EP527126HVZ |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis E virus genotype 1 Protein ORF3 (ORF3) expressed in E.coli |
Hepatitis B Virus E Antigen (HBeAg) |
REC31677-100 |
The Native Antigen Company |
0.1 |
EUR 456.72 |
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
Hepatitis B Virus E Antigen (HBeAg) |
REC31677-500 |
The Native Antigen Company |
0.5 |
EUR 1941.06 |
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
Dengue virus 1 E recombinant antigen |
8812 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Dengue virus 1 E recombinant antigen for ELISA,WB. |
Dengue virus 2 E recombinant antigen |
8813 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Dengue virus 2 E recombinant antigen for ELISA,WB. |
Dengue virus 3 E recombinant antigen |
8814 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Dengue virus 3 E recombinant antigen for ELISA,WB. |
Dengue virus 4 E recombinant antigen |
8815 |
Virostat |
100 ug |
EUR 477.6 |
Description: This is Dengue virus 4 E recombinant antigen for ELISA,WB. |
Hepatitis B Virus e-Antigen Protein |
20-abx260781 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis B Virus E Antigen Antibody |
20-abx134030 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis B Virus E Antigen Antibody |
20-abx134031 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis B Virus e antigen, Antibody |
GWB-980E8B |
GenWay Biotech |
1 mg |
Ask for price |
Hepatitis E Virus Capsid Protein (ORF2), His-tag |
REC31653-100 |
The Native Antigen Company |
0.1 |
EUR 354.66 |
Description: Recombinant Hepatitis E (HEV) ORF2. Protein contains a C-terminal His-tag. |
Hepatitis E Virus Capsid Protein (ORF2), His-tag |
REC31653-500 |
The Native Antigen Company |
0.5 |
EUR 1252.79 |
Description: Recombinant Hepatitis E (HEV) ORF2. Protein contains a C-terminal His-tag. |
Hepatitis E Virus ORF 2 Recombinant Protein beta-galactosidase liquid |
IHEPEHEPEORF2R10UG |
Innovative research |
each |
EUR 762 |
|
Description: Hepatitis E Virus ORF 2 Recombinant Protein beta-galactosidase liquid |
Hepatitis E Virus ORF 3 Recombinant Protein beta-galactosidase liquid |
IHEPEHEPEORF3R10UG |
Innovative research |
each |
EUR 762 |
|
Description: Hepatitis E Virus ORF 3 Recombinant Protein beta-galactosidase liquid |
Hepatitis E virus genotype 3 Capsid protein (ORF2) |
1-CSB-YP897430HHAM |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis E virus genotype 3 Capsid protein(ORF2),partial expressed in Yeast |
Hepatitis E virus genotype 1 Capsid protein (ORF2) |
1-CSB-EP727851HVZ |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis E virus genotype 1 Capsid protein(ORF2) expressed in E.coli |
Hepatitis E virus genotype 3 Capsid protein (ORF2) |
1-CSB-EP897430HHAMa2 |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis E virus genotype 3 Capsid protein(ORF2),partial expressed in E.coli |
Hepatitis E virus genotype 1 Capsid protein (ORF2) |
1-CSB-BP727851HVZ |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis E virus genotype 1 Capsid protein(ORF2) expressed in Baculovirus |
Recombinant Hepatitis B Virus e-Antigen |
7-07423 |
CHI Scientific |
5µg |
Ask for price |
Recombinant Hepatitis B Virus e-Antigen |
7-07424 |
CHI Scientific |
25µg |
Ask for price |
Recombinant Hepatitis B Virus e-Antigen |
7-07425 |
CHI Scientific |
1000µg |
Ask for price |
Viridicatin |
V023-1MG |
TOKU-E |
1 mg |
EUR 146.96 |
|
Description: C15H11NO2 |
Viridicatin |
V023-5MG |
TOKU-E |
5 mg |
EUR 513.71 |
|
Description: C15H11NO2 |
Zika Virus VLP (E, prM/M Proteins) |
ZIKV-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 864.96 |
Description: Recombinant Zika Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. |
Zika Virus VLP (E, prM/M Proteins) |
ZIKV-VLP-250 |
The Native Antigen Company |
0.25 |
EUR 1823.05 |
Description: Recombinant Zika Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. |
Virginiamycin S1 |
V014-25MG |
TOKU-E |
25 mg |
EUR 756.48 |
|
Description: C43H49N7O10 |
Virginiamycin S1 |
V014-5MG |
TOKU-E |
5 mg |
EUR 216.32 |
|
Description: C43H49N7O10 |
Virginiamycin B |
V021-25MG |
TOKU-E |
25 mg |
EUR 943.76 |
|
Description: C45H54N8O10 |
Virginiamycin B |
V021-5MG |
TOKU-E |
5 mg |
EUR 207.65 |
|
Description: C45H54N8O10 |
Virginiamycin |
V022-25MG |
TOKU-E |
25 mg |
EUR 751.28 |
|
Description: C28H35N3O7 (for M1) C43H49N7O10 (for S1) |
Virginiamycin |
V022-5MG |
TOKU-E |
5 mg |
EUR 214.59 |
|
Description: C28H35N3O7 (for M1) C43H49N7O10 (for S1) |
Virginiamycin >95% |
V030-100MG |
TOKU-E |
100mg |
EUR 207.03 |
|
Description: C28H35N3O7(for M1) C43H49N7O10(for S1) |
Virginiamycin >95% |
V030-500MG |
TOKU-E |
500mg |
EUR 421.47 |
|
Description: C28H35N3O7(for M1) C43H49N7O10(for S1) |
West Nile Virus E protein (His tag) |
80-1339 |
Fitzgerald |
100 ug |
EUR 199 |
|
Description: Purified recombinant West Nile Virus E protein (His tag) |
Hepatitis E Virus Mosaic ORF2 / ORF3 38.5 kDa Protein |
20-abx260137 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Recombinant (E.Coli) Hepatitis E Virus (HEV) ORF2 (633-659) |
RP-529 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
Recombinant (E.Coli) Hepatitis E Virus (HEV) ORF2 (403-461) |
RP-530 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
Viridicatumtoxin |
V024-1MG |
TOKU-E |
1 mg |
EUR 207.65 |
|
Description: C30H31NO10 |
Viridicatumtoxin |
V024-5MG |
TOKU-E |
5 mg |
EUR 726.13 |
|
Description: C30H31NO10 |
Hepatitis E virus (ratHEV) RT PCR kit |
RTq-V372-100R |
Bioingentech |
100T |
EUR 1573.2 |
Hepatitis E virus (ratHEV) RT PCR kit |
RTq-V372-150R |
Bioingentech |
150T |
EUR 2144.4 |
Hepatitis E virus (ratHEV) RT PCR kit |
RTq-V372-50R |
Bioingentech |
50T |
EUR 1155.6 |
Hepatitis E virus One-Step PCR kit |
Oneq-H498-100R |
Bioingentech |
100T |
EUR 1932 |
Hepatitis E virus One-Step PCR kit |
Oneq-H498-150R |
Bioingentech |
150T |
EUR 2646 |
Hepatitis E virus One-Step PCR kit |
Oneq-H498-50R |
Bioingentech |
50T |
EUR 1410 |
Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31:
As a novel enteropathogenic coronavirus, porcine deltacoronavirus (PDCoV) warrants additional investigation. On this examine, a Chinese language PDCoV pressure, designated CHN-HN-1601, was remoted from the feces of a diarrheic piglet. After plaque purification, the genome was decided which shared 97.5%-99.5% nucleotide identities with 71 consultant PDCoV strains obtainable within the GenBank. The pathogenic properties of CHN-HN-1601 have been evaluated utilizing 5-day-old piglets.
All inoculated piglets developed extreme diarrhea from 2 days post-infection (dpi) onwards. To our shock, two intervals of diarrhea ranging from 2 to 7 dpi and from 13 to 19 dpi have been noticed in affected piglets in the course of the experiment. Fecal viral shedding of the inoculated piglets was detected by real-time RT-PCR, with viral shedding peaked at Four and 16 dpi, respectively. At necropsy at 5 dpi, the primary gross lesions included clear, thin-walled and gas-distended intestines containing yellow watery contents.
Additional histopathological examinations, together with hematoxylin and eosin staining, immunohistochemistry, RNAscope in situ hybridization revealed that the virus an infection prompted extreme villous atrophy of the small intestines, with PDCoV antigen and RNA primarily distributed within the cytoplasm of the villous epithelial cells of jejunum and ileum in piglets.
The dynamic manufacturing of PDCoV-specific IgG and neutralizing antibodies in serum of the affected piglets was additionally assessed utilizing a complete virus-based ELISA and an immunofluorescence assay-based neutralization take a look at, respectively. Moreover, a full-length cDNA infectious clone of CHN-HN-1601 was constructed utilizing a bacterial synthetic chromosome system.
The rescued virus exhibited in vitro progress and pathogenic properties just like the parental virus. Taken collectively, our examine not solely enriches the knowledge of PDCoV, but in addition offers a helpful reverse genetics platform for additional pathogenesis exploration of the virus.
metabolism
Aim: Uridine diphospho-glucuronosyltransferases (UGTs) are membrane-bound enzymes that catalyze the conjugation of glucuronic acid onto a varied set of xenobiotics. Horses successfully and extensively glucuronidate numerous xenobiotics, along with opioids, making UGTs an very important group of drug-metabolizing enzymes for the clearance of remedy. Recombinant enzymes have allowed researchers to characterize the metabolism of a variety of remedy. The primary objective was to clone, particular and characterize equine UGTs using remedy characterised as UGT substrates in several species. A secondary objective was to characterize the in vitro metabolism of morphine in horses.
Study design: In vitro drug metabolism look at using liver microsomes and recombinant enzyme strategies.
Animals: Liver microsomes and RNA from tissue collected from two Thoroughbred mares euthanized for various causes.
Methods: Based totally on homology to the human UGT2B7, Four equine UGT variants have been expressed: UGT1A1, UGT2A1, UGT2B31 and UGT2B4. cDNA sequences have been cloned and ensuing protein expressed in a baculovirus expression system. Efficiency of the enzymes was assessed using 4-methylumbelliferone, testosterone, diclofenac and ketoprofen. Recombinant enzyme, administration cells, equine liver microsomes and human UGT2B7 supersomes have been then incubated with morphine. Concentrations of metabolites have been measured using liquid chromatography-tandem mass spectrometry and enzyme kinetics determined.
Outcomes: 4-Methylumbelliferone was glucuronidated by all expressed equine UGTs. Testosterone glucuronide was not produced by any of the expressed enzymes, and diclofenac glucuronide and ketoprofen glucuronide have been produced by UG2A1 and UGT1A1, respectively. UGT2B31 metabolized morphine to morphine-3-glucuronide and low concentrations of morphine-6-glucuronide.
Conclusions and scientific relevance: That’s the major worthwhile expression of helpful recombinant equine UGTs. UGT2B31 contributes to the glucuronidation of morphine; nonetheless, it is most likely not the first metabolizing enzyme. These outcomes warrant further investigation of equine UGTs, along with expression of additional enzymes and extra characterization of UGT2B31 as a contributor to morphine metabolism.
An progressive genosensor for the monitoring of Leishmaniaspp sequence using binding of pDNA to cDNA based totally on Cit-AgNPs
Leishmaniasis regarded as basically probably the most important epidemic-prone diseases based mostly on the World Nicely being Group. Early diagnoses and treatment of Leishmania an an infection is an efficient downside since, it has no symptom and is resistance to remedy. Subsequently, there’s an urgent need for delicate and precise detection of this pathogen.
On this look at, a model new approach was developed for optical biosensing of Leishmaniaspp sequence based totally on hybridization of Citrate capped Ag nanoparticles bonded to explicit single stranded DNA probe of Leishmania spp. Aggregation of the Citrate capped Ag nanoparticles inside the existence or lack of a cDNA sequence of Leishmania, set off eye catching and considerable very important alter inside the UV-vis.
The obtained low prohibit of quantification (LLOQ) of was achieved as 1ZM. Based totally on experimental ends in optimum conditions, quick bioanalysis of Leishmaniaspp sequence was carried out (2 min). So, this probe may be utilized for the scientific evaluation of this pathogen and an an infection sickness.
Improvement of a Full-Size Infectious Cdna Clone of the Grapevine Berry Inside Necrosis Virus
Grapevine berry interior necrosis virus (GINV) belongs to the genus Trichovirus within the household Betaflexiviridae. The GINV isolate LN_BETA_RS was obtained from a “Beta” grapevine (Vitis riparia × Vitis labrusca) exhibiting chlorotic mottling and ring spot in Xingcheng, Liaoning Province, China. To confirm the correlation between GINV and grapevine chlorotic mottling and ring spot illness, we constructed an infectious cDNA clone of GINV isolate LN_BETA_RS utilizing the seamless meeting strategy.
Utilized remedies of agroinfiltration infectious cDNA confirmed systemic GINV an infection of the Nicotianaoccidentalis 37B by reverse transcription polymerase chain response (RT-PCR) and transmission electron microscopy, exhibiting chlorotic mottling signs on leaves. Infectious cDNA was additionally transmitted to new wholesome N. occidentalis crops via rub-inoculation. Furthermore, the cDNA clone was agroinfiltrated into “Beta” and “Thompson Seedless” grapevine plantlets, and the inoculated grapevines exhibited leaf chlorotic mottling and ringspot in the course of the two years of statement.
GINV-inoculated “Beta” grapevines had severe leaf chlorotic mottling and ringspot signs on the entire plant, whereas comparatively few signs have been noticed on the leaves of agroinoculated “Thompson Seedless” grapevines in early spring and solely weak ring spot progressively appeared later within the prime younger leaves. Our experiments fulfilled Koch’s postulates and revealed the causative position of GINV in grapevine chlorotic mottling and ring spot illness.
A pressure of porcine deltacoronavirus: genomic characterization, pathogenicity and its full-length cDNA infectious clone
As a novel enteropathogenic coronavirus, porcine deltacoronavirus (PDCoV) warrants additional investigation. On this examine, a Chinese language PDCoV pressure, designated CHN-HN-1601, was remoted from the feces of a diarrheic piglet. After plaque purification, the genome was decided which shared 97.5%-99.5% nucleotide identities with 71 consultant PDCoV strains obtainable within the GenBank.
The pathogenic properties of CHN-HN-1601 have been evaluated utilizing 5-day-old piglets. All inoculated piglets developed extreme diarrhea from 2 days post-infection (dpi) onwards. To our shock, two intervals of diarrhea ranging from 2 to 7 dpi and from 13 to 19 dpi have been noticed in affected piglets in the course of the experiment. Fecal viral shedding of the inoculated piglets was detected by real-time RT-PCR, with viral shedding peaked at Four and 16 dpi, respectively. At necropsy at 5 dpi, the primary gross lesions included clear, thin-walled and gas-distended intestines containing yellow watery contents.
Additional histopathological examinations, together with hematoxylin and eosin staining, immunohistochemistry, RNAscope in situ hybridization revealed that the virus an infection prompted extreme villous atrophy of the small intestines, with PDCoV antigen and RNA primarily distributed within the cytoplasm of the villous epithelial cells of jejunum and ileum in piglets. The dynamic manufacturing of PDCoV-specific IgG and neutralizing antibodies in serum of the affected piglets was additionally assessed utilizing a complete virus-based ELISA and an immunofluorescence assay-based neutralization take a look at, respectively.
Moreover, a full-length cDNA infectious clone of CHN-HN-1601 was constructed utilizing a bacterial synthetic chromosome system. The rescued virus exhibited in vitro progress and pathogenic properties just like the parental virus. Taken collectively, our examine not solely enriches the knowledge of PDCoV, but in addition offers a helpful reverse genetics platform for additional pathogenesis exploration of the virus.
Recombinant Orf Virus VEGFE Protein [His] |
VAng-Lsx0418-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Orf virus VEGF-E Recombinant Protein |
300-044 |
ReliaTech |
5 µg |
EUR 136.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
300-044S |
ReliaTech |
2 µg |
EUR 73.5 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
300-045 |
ReliaTech |
20 µg |
EUR 357 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046 |
ReliaTech |
20 µg |
EUR 194.25 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046S |
ReliaTech |
5 µg |
EUR 94.5 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
PROTQ2F842 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
QP10912-1mg |
EnQuireBio |
1mg |
EUR 6181.2 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
QP10912-2ug |
EnQuireBio |
2ug |
EUR 186 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
QP10912-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Anti-Orf Virus VEGF-E Antibody |
102-PA70 |
ReliaTech |
50 µg |
EUR 115.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
VEGF E (Orf Virus) |
cyt-263 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
Human PDGFC / VEGFE, Fc Tag |
E24PHA208 |
EnoGene |
50 μg |
EUR 180 |
Human PDGFC / VEGFE, His Tag |
E24PHA209 |
EnoGene |
50 μg |
EUR 225 |
Cynomolgus / Rhesus Macaque PDGFC / VEGFE, Fc Tag |
E24PCA081 |
EnoGene |
50 μg |
EUR 180 |
Cynomolgus / Rhesus Macaque PDGFC / VEGFE, His Tag |
E24PCA082 |
EnoGene |
50 μg |
EUR 225 |
Virus Measles Virus (MeV) Protein |
abx670263-1ml |
Abbexa |
1 ml |
EUR 543.6 |
|
Virus West Nile Virus (WNV) Protein |
abx670276-100ug |
Abbexa |
100 ug |
EUR 794.4 |
|
Virus Hepatitis A Virus (HAV) Protein |
abx670259-1ml |
Abbexa |
1 ml |
EUR 427.2 |
|
Virus Yellow Fever Virus (YFV) Protein |
abx670277-100ug |
Abbexa |
100 ug |
EUR 644.4 |
|
Virus Varicella Zoster Virus (VZV) Protein |
abx670269-1ml |
Abbexa |
1 ml |
EUR 794.4 |
|
Hepatitis E virus ORF 3 Recombinant Protein |
53-335 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-336 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-337 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Virus Respiratory Syncytial Virus (RSV) Protein |
abx670078-01mg |
Abbexa |
0.1 mg |
EUR 594 |
|
Virus Parainfluenza Virus 1 (HPIV-1) Protein |
abx670265-1ml |
Abbexa |
1 ml |
EUR 794.4 |
|
Virus Parainfluenza Virus 2 (HPIV-2) Protein |
abx670266-1ml |
Abbexa |
1 ml |
EUR 710.4 |
|
Virus Parainfluenza Virus 3 (HPIV-3) Protein |
abx670267-1ml |
Abbexa |
1 ml |
EUR 710.4 |
|
Rat virus protein |
30-1272 |
Fitzgerald |
1 mg |
EUR 195 |
|
Description: Purified native Rat virus protein (Mouse) |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
20-abx263083 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-10mg |
Abbexa |
10 mg |
EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-25mg |
Abbexa |
25 mg |
EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-5mg |
Abbexa |
5 mg |
EUR 225 |
Virus Herpes Simplex Virus 2 (HSV-2) Protein |
abx670261-1ml |
Abbexa |
1 ml |
EUR 360 |
|
Mumps virus protein |
30-1309 |
Fitzgerald |
1 mg |
EUR 245 |
|
Description: Purified native Mumps virus protein |
Mumps virus protein |
30-1310 |
Fitzgerald |
1 mg |
EUR 200 |
|
Description: Purified native Mumps virus protein |
Mumps virus protein |
30-AM18 |
Fitzgerald |
1 ml |
EUR 234 |
|
Description: Purified Mumps virus protein |
Mumps virus protein |
30R-AM029 |
Fitzgerald |
1 ml |
EUR 553 |
|
Description: Purified native Mumps virus protein |
Mumps Virus Protein |
abx670264-1ml |
Abbexa |
1 ml |
EUR 543.6 |
|
Mumps Virus Protein |
abx670264-100g |
Abbexa |
100 µg |
EUR 362.5 |
Hepatitis E Virus ORF3 Protein |
20-abx260138 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF3 Protein |
abx260138-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF3 Protein |
abx260138-5g |
Abbexa |
5 µg |
EUR 350 |
Measles virus protein |
30-1308 |
Fitzgerald |
1 mg |
EUR 200 |
|
Description: Purified native Measles virus protein |
Rubella virus protein |
30-1344 |
Fitzgerald |
1 ml |
EUR 497 |
|
Description: Purified native Rubella virus protein (Grade III) |
Rubeola virus protein |
30-AR23 |
Fitzgerald |
1 ml |
EUR 287 |
|
Description: Purified Rubeola virus protein |
Rubella Virus Protein |
abx670270-1mg |
Abbexa |
1 mg |
EUR 1212 |
|
Rubella Virus Protein |
abx670271-1mg |
Abbexa |
1 mg |
EUR 2163.6 |
|
Varicella Zoster Virus ORF26 Protein |
20-abx260176 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Varicella Zoster Virus ORF26 Protein |
abx260176-20g |
Abbexa |
20 µg |
EUR 950 |
Varicella Zoster Virus ORF26 Protein |
abx260176-5g |
Abbexa |
5 µg |
EUR 350 |
Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics anti-PDGF-C) |
E24CHA317 |
EnoGene |
100 μg |
EUR 225 |
Description: Available in various conjugation types. |
Varicella Zoster Virus ORF9 Protein |
20-abx260175 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Varicella Zoster Virus ORF9 Protein |
abx260175-20g |
Abbexa |
20 µg |
EUR 950 |
Varicella Zoster Virus ORF9 Protein |
abx260175-5g |
Abbexa |
5 µg |
EUR 350 |
Virus Herpes Simplex Virus 1 (HSV-1 Antibody) Protein |
abx670260-1ml |
Abbexa |
1 ml |
EUR 360 |
|
Zika virus NS1 protein |
30-1931 |
Fitzgerald |
100 ug |
EUR 3450 |
|
Description: Recombinant Zika virus NS1 protein |
Zika virus NS1 protein |
30-1936 |
Fitzgerald |
100 ug |
EUR 1700 |
|
Description: Recombinant Zika virus NS1 protein with His tag |
Zika virus NS1 Protein |
E40VAG345 |
EnoGene |
20ug |
EUR 495 |
Ebola Virus NP protein |
80-1411 |
Fitzgerald |
100 ug |
EUR 132 |
|
Description: Purified Recombinant Ebola Nucleoprotein antigen (Zaire strain) |
Zika Virus NS1 Protein |
abx061380-1mg |
Abbexa |
1 mg |
EUR 1722 |
|
Nipah Virus G Protein |
abx160012-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Zika Virus NS1 Protein |
abx061380-100g |
Abbexa |
100 µg |
Ask for price |
Zika Virus NS1 Protein |
abx061380-10g |
Abbexa |
10 µg |
EUR 1725 |
Zika Virus NS1 Protein |
abx061380-50g |
Abbexa |
50 µg |
Ask for price |
Usutu Virus NS1 Protein |
USUV-NS1-100 |
The Native Antigen Company |
0.1 |
EUR 473.31 |
Description: Recombinant Usutu Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
Usutu Virus NS1 Protein |
USUV-NS1-500 |
The Native Antigen Company |
0.5 |
EUR 1802.64 |
Description: Recombinant Usutu Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
Rubella virus E2 protein |
30-1281 |
Fitzgerald |
1 mg |
EUR 1195 |
|
Description: Purified recombinant Rubella virus E2 protein |
Ebola Virus VP40 protein |
30-1837 |
Fitzgerald |
100 ug |
EUR 136 |
|
Description: Recombinant Ebola Virus VP40 Matrix protein |
Rubella Virus E1 protein |
80-1059 |
Fitzgerald |
1 mg |
EUR 1680 |
|
Description: Purified recombinant Rubella Virus E1 protein |
Rubella Virus E2 Protein |
abx060648-1mg |
Abbexa |
1 mg |
EUR 2055.6 |
|
Rubella Virus E2 Protein |
abx060649-1mg |
Abbexa |
1 mg |
EUR 1713.6 |
|
Rubella Virus E2 Protein |
20-abx260148 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Rubella Virus E2 Protein |
abx260148-20g |
Abbexa |
20 µg |
EUR 950 |
Rubella Virus E2 Protein |
abx260148-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (452-617) Protein |
20-abx260268 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
20-abx260269 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
20-abx260270 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (452-617) Protein |
abx260268-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF2 (452-617) Protein |
abx260268-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (633-659) Protein |
abx260269-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (633-659) Protein |
abx260269-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (403-461) Protein |
abx260270-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (403-461) Protein |
abx260270-5g |
Abbexa |
5 µg |
EUR 350 |
Norwalk virus Capsid protein VP1 (ORF2) |
1-CSB-YP767779NBAY |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Norwalk virus Capsid protein VP1(ORF2) expressed in Yeast |
Norwalk virus Capsid protein VP1 (ORF2) |
1-CSB-MP767779NBAY |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Description: Recombinant Norwalk virus Capsid protein VP1(ORF2) expressed in Mammalian cell |
Dengue Virus Typ1 Protein |
abx069812-100ug |
Abbexa |
100 ug |
EUR 1161.6 |
|
Dengue Virus Typ1 Protein |
abx069812-25g |
Abbexa |
25 g |
Ask for price |
Dengue Virus Typ1 Protein |
abx069812-5g |
Abbexa |
5 g |
EUR 1150 |
Measles Virus (MeV) Protein |
abx670263-100g |
Abbexa |
100 µg |
EUR 362.5 |
Hepatitis A Virus protein |
30-1929 |
Fitzgerald |
1 ml |
EUR 95 |
|
Description: Purified Native Hepatitis A Virus protein |
Hepatitis C Virus protein |
30-1989 |
Fitzgerald |
1 mg |
EUR 595 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-1990 |
Fitzgerald |
1 mg |
EUR 595 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-1991 |
Fitzgerald |
1 mg |
EUR 595 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis E Virus protein |
30-AH29 |
Fitzgerald |
1 mg |
EUR 895 |
|
Description: Hepatitis E Virus recombinant protein |
Hepatitis C Virus protein |
30-AH64 |
Fitzgerald |
1 mg |
EUR 495 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-AH66 |
Fitzgerald |
1 mg |
EUR 168 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-AH67 |
Fitzgerald |
1 mg |
EUR 807.6 |
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-AH68 |
Fitzgerald |
1 mg |
EUR 168 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-AH72 |
Fitzgerald |
1 mg |
EUR 695 |
|
Description: Purified recombinant Hepatitis C Virus protein |
Hepatitis C Virus protein |
30-AH95 |
Fitzgerald |
1 mg |
EUR 400 |
|
Description: Purified recombinant Hepatitis C Virus Core protein |
Hepatitis A Virus protein |
30R-AH015 |
Fitzgerald |
1 ml |
EUR 1028 |
|
Description: Purified native Hepatitis A Virus protein |
Hepatitis E Virus protein |
30R-AH054X |
Fitzgerald |
500 ug |
EUR 840 |
|
Description: Hepatitis E Virus Mosaic recombinant protein |
Hepatitis D Virus protein |
30R-AH055X |
Fitzgerald |
500 ug |
EUR 875 |
|
Description: Hepatitis D Virus recombinant protein |
Hepatitis D Virus Protein |
abx060542-1mg |
Abbexa |
1 mg |
EUR 1888.8 |
|
Hepatitis D Virus Protein |
20-abx260136 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Powassan Virus NS1 Protein |
REC31643-100 |
The Native Antigen Company |
0.1 |
EUR 473.31 |
Description: Recombinant Powassan Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal 6x His-tag. The oligomerisation state is predominantly hexameric. |
Powassan Virus NS1 Protein |
REC31643-500 |
The Native Antigen Company |
0.5 |
EUR 1890.66 |
Description: Recombinant Powassan Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal 6x His-tag. The oligomerisation state is predominantly hexameric. |
Hepatitis D Virus Protein |
abx260136-10g |
Abbexa |
10 µg |
EUR 950 |
Hepatitis D Virus Protein |
abx260136-2g |
Abbexa |
2 µg |
EUR 350 |
Hepatitis D Virus Protein |
abx060542-5mg |
Abbexa |
5 mg |
Ask for price |
Polyoma virus protein (Mouse) |
30-1271 |
Fitzgerald |
1 mg |
EUR 195 |
|
Description: Purified native Polyoma virus protein |
Zika virus envelope protein |
30-1932 |
Fitzgerald |
100 ug |
EUR 3400 |
|
Description: Recombinant Zika virus envelope protein |
Zika virus envelope protein |
30-1935 |
Fitzgerald |
100 ug |
EUR 1700 |
|
Description: Recombinant Zika virus envelope protein |
Zika Virus Envelope Protein |
abx061381-1mg |
Abbexa |
1 mg |
EUR 1722 |
|
Zika Virus Envelope Protein |
abx160022-1mg |
Abbexa |
1 mg |
EUR 1746 |
|
Zika Virus Envelope Protein |
abx061381-100g |
Abbexa |
100 µg |
Ask for price |
Zika Virus Envelope Protein |
abx061381-10g |
Abbexa |
10 µg |
EUR 1725 |
Zika Virus Envelope Protein |
abx061381-50g |
Abbexa |
50 µg |
Ask for price |
Mouse Leukemia virus protein |
30-1273 |
Fitzgerald |
1 mg |
EUR 195 |
|
Description: Purified native Mouse Leukemia virus protein |
Chikungunya virus E1 protein |
30-1942 |
Fitzgerald |
100 ug |
EUR 1500 |
|
Description: Recombinant Chikungunya virus E1 protein - wild type |
Virus Adenovirus (ADV) Protein |
abx670001-1ml |
Abbexa |
1 ml |
EUR 744 |
|
Rubella Virus Capsid Protein |
abx060645-1mg |
Abbexa |
1 mg |
EUR 2180.4 |
|
Virus Hepatitis B Virus Surface Antigen ay (HBsAg ay) Protein |
abx670099-01mg |
Abbexa |
0.1 mg |
EUR 678 |
|
Virus Hepatitis B Virus Surface Antigen ad (HBsAg ad) Protein |
abx670255-01mg |
Abbexa |
0.1 mg |
EUR 844.8 |
|
Wesselsbron Virus NS1 protein |
REC31698-100 |
The Native Antigen Company |
0.1 |
EUR 473.31 |
Description: Recombinant Wesselsbron Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
Wesselsbron Virus NS1 protein |
REC31698-500 |
The Native Antigen Company |
0.5 |
EUR 1890.66 |
Description: Recombinant Wesselsbron Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
Virus Hepatitis B Virus 320 Core Antigen (HBV 320 Core Ag) Protein |
abx670003-50ug |
Abbexa |
50 ug |
EUR 493.2 |
|
Canine Distemper virus protein |
30-1251 |
Fitzgerald |
1 mg |
EUR 400 |
|
Description: Purified native Canine Distemper virus protein |
Ectromelia virus protein (Mouse) |
30-1263 |
Fitzgerald |
1 mg |
EUR 195 |
|
Description: Purified native Ectromelia virus protein (Mouse) |
Chikungunya virus gpE2 protein |
30-1939 |
Fitzgerald |
100 ug |
EUR 1560 |
|
Description: Recombinant Chikungunya virus Glycoprotein E2 protein - wild type |
Chikungunya virus gpE1 protein |
30-1940 |
Fitzgerald |
100 ug |
EUR 1560 |
|
Description: Recombinant Chikungunya virus Glycoprotein E1 protein - wild type |
Chikungunya virus gpE1 protein |
30-1944 |
Fitzgerald |
100 ug |
EUR 1184 |
|
Description: Recombinant Chikungunya virus Glycoprotein E1 protein - wild type |
West Nile Virus NS1 protein |
80-1546 |
Fitzgerald |
100 ug |
EUR 541.2 |
Description: Purified Recombinant West Nile Virus NS1 protein (His tag) |
West Nile Virus NS1 Protein |
WNV-NS1-100 |
The Native Antigen Company |
0.1 |
EUR 318.94 |
Description: Recombinant West Nile Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
West Nile Virus NS1 Protein |
WNV-NS1-500 |
The Native Antigen Company |
0.5 |
EUR 1305.1 |
Description: Recombinant West Nile Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
West Nile Virus (WNV) Protein |
abx670276-50g |
Abbexa |
50 µg |
EUR 587.5 |
Virus Cytomegalovirus (CMV) Protein |
abx670257-1ml |
Abbexa |
1 ml |
EUR 493.2 |
|
Minute Virus of Mice protein |
30-1262 |
Fitzgerald |
1 mg |
EUR 195 |
|
Description: Purified native Minute Virus of Mice protein (Mouse) |
Dengue Virus Type 2 Protein |
abx670258-1ml |
Abbexa |
1 ml |
EUR 1345.2 |
|
Dengue Virus Type 2 Protein |
abx069813-100ug |
Abbexa |
100 ug |
EUR 1161.6 |
|
Dengue Virus Type 3 Protein |
abx069814-100ug |
Abbexa |
100 ug |
EUR 1161.6 |
|
Dengue Virus Type 3 Protein |
abx069815-100ug |
Abbexa |
100 ug |
EUR 1161.6 |
|
Dengue Virus Type 4 Protein |
abx069816-100ug |
Abbexa |
100 ug |
EUR 1161.6 |
|
Dengue Virus Type 4 Protein |
abx069817-100ug |
Abbexa |
100 ug |
EUR 1161.6 |
|
Dengue Virus Type 2 Protein |
abx069813-1g |
Abbexa |
1 g |
EUR 1237.5 |
Dengue Virus Type 2 Protein |
abx069813-5g |
Abbexa |
5 g |
Ask for price |
Dengue Virus Type 3 Protein |
abx069814-10g |
Abbexa |
10 g |
EUR 1237.5 |
Dengue Virus Type 3 Protein |
abx069815-5g |
Abbexa |
5 g |
EUR 1237.5 |
Dengue Virus Type 4 Protein |
abx069816-5g |
Abbexa |
5 g |
EUR 1237.5 |
Dengue Virus Type 4 Protein |
abx069817-5g |
Abbexa |
5 g |
EUR 1237.5 |
Dengue Virus Type 2 Protein |
abx670258-100g |
Abbexa |
100 µg |
EUR 1062.5 |
West Nile virus protein (Horse) |
30-1261 |
Fitzgerald |
250 ug |
EUR 395 |
|
Description: Purified recombinant West Nile virus protein (Horse) |
Hepatitis B Virus x Protein |
20-abx262147 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Vaccinia virus Protein K3 (K3L) |
1-CSB-EP321831VAA |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Vaccinia virus Protein K3 (K3L) expressed in E.coli |
Vaccinia virus Protein E3 (E3L) |
1-CSB-EP322729VAA |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Vaccinia virus Protein E3 (E3L) expressed in E.coli |
Hepatitis C Virus E2 Protein |
20-abx260782 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis C Virus E2 Protein |
abx260782-10g |
Abbexa |
10 µg |
EUR 325 |
Hepatitis C Virus E2 Protein |
abx260782-2g |
Abbexa |
2 µg |
EUR 225 |
Hepatitis B Virus x Protein |
abx262147-10mg |
Abbexa |
10 mg |
EUR 6575 |
Hepatitis B Virus x Protein |
abx262147-5mg |
Abbexa |
5 mg |
EUR 387.5 |
Potato leafroll virus Major capsid protein (ORF3) |
1-CSB-EP325916PQU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Potato leafroll virus Major capsid protein (ORF3) expressed in E.coli |
Japanese Encephalitis Virus Protein |
abx060634-100ug |
Abbexa |
100 ug |
EUR 693.6 |
|
Japanese Encephalitis Virus Protein |
20-abx260165 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Japanese Encephalitis Virus Protein |
abx260165-20g |
Abbexa |
20 µg |
EUR 950 |
Japanese Encephalitis Virus Protein |
abx260165-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis C Virus protein (HRP) |
65-IH20 |
Fitzgerald |
1 ml |
EUR 695 |
|
Description: Purified recombinant Hepatitis C Virus protein (HRP) |
Hepatitis E Virus protein (HRP) |
65-IH35 |
Fitzgerald |
1 ml |
EUR 1100 |
|
Description: Purified recombinant Hepatitis E Virus protein (HRP) |
Rubella virus protein (Grade 1) |
30-1330 |
Fitzgerald |
1 ml |
EUR 786 |
|
Description: Purified Native Rubella virus protein (Grade 1) |
Rubella virus protein (Grade 2) |
30-1331 |
Fitzgerald |
1 mg |
EUR 2018.4 |
Description: Purified Native Rubella virus protein (Grade 2) |
Hepatitis C Virus NS3 protein |
30-AH59 |
Fitzgerald |
100 ug |
EUR 210 |
|
Description: Purified recombinant Hepatitis C Virus NS3 protein |
Hepatitis C Virus NS4 protein |
30-AH60 |
Fitzgerald |
200 ug |
EUR 725 |
|
Description: Purified recombinant Hepatitis C Virus NS4 protein |
Hepatitis C Virus NS3 protein |
30-AH70 |
Fitzgerald |
1 mg |
EUR 895 |
|
Description: Purified recombinant Hepatitis C Virus NS3 protein |
Rubeola virus (Level 1) protein |
30-AR30 |
Fitzgerald |
1 ml |
EUR 341 |
|
Description: Purified native Rubeola virus (Level 1) protein |
Hepatitis C Virus NS3 protein |
30R-AH004 |
Fitzgerald |
1 mg |
EUR 1818 |
|
Description: Purified recombinant Hepatitis C Virus NS3 protein |
Hepatitis C Virus NS4 protein |
30R-AH007 |
Fitzgerald |
1 mg |
EUR 1400 |
|
Description: Hepatitis C Virus NS4 Mosaic recombinant protein |
Hepatitis C Virus NS4 protein |
30R-AH008 |
Fitzgerald |
100 ug |
EUR 333 |
|
Description: Hepatitis C Virus NS4 Mosaic recombinant protein |
Hepatitis C Virus NS5 protein |
30R-AH009 |
Fitzgerald |
1 mg |
EUR 1750 |
|
Description: Purified recombinant Hepatitis C Virus NS5 protein |
Hepatitis C Virus NS5 protein |
30R-AH009x |
Fitzgerald |
500 ug |
EUR 867 |
|
Description: Hepatitis C Virus NS5 Genotype-1a (2322-2423) recombinant protein |
Hepatitis C Virus NS4 protein |
30R-AH061 |
Fitzgerald |
100 ug |
EUR 840 |
|
Description: Hepatitis C Virus NS4 (1916-1947 a.a.) recombinant protein |
Hepatitis C Virus NS5 protein |
30R-AH075 |
Fitzgerald |
100 ug |
EUR 1819 |
|
Description: Purified recombinant Hepatitis C Virus NS5 protein |
Rabies virus Matrix protein (M) |
1-CSB-YP322192RAI |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Rabies virus Matrix protein(M) expressed in Yeast |
Source :
- Gentaur
- NCBI